Humoral response to recombinant hepatitis B virus vaccine at birth: Role of HLA and beyond

Clinical Immunology

Volumn 97, Issue 3, 2000, Pages 234-240

  Martinetti, Miryam ^a   De Silvestri, Annalisa ^a   Belloni, Cesare ^a   Pasi, Annamaria ^a   Tinelli, Carmine ^a   Pistorio, Angela ^a   Salvaneschi, Laura ^a   Rondini, Giorgio ^a   Avanzini, Maria Antonia ^a   Cuccia, Mariaclara ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Allergy; Celiac disease; HLA; Insulin dependent diabetes mellitus; Recombinant HBV vaccine

Indexed keywords

HEPATITIS B VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC RISK; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; HUMORAL IMMUNITY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033668895     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4933     Document Type: Article

References (31)

1. A controlled trial of the efficacy of the hepatitis B vaccine (Hepatavax B): A final report
2. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination
3. HLA-associated non-responsiveness to Hepatitis B vaccine
4. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings
5. Genetic prediction of nonresponse to hepatitis B vaccine
6. The cellular basis for lack of antibody response to hepatitis B vaccine in humans
7. Anti-HBV neonatal immunization with recombinant vaccine. Part I. Critical appraisal for a long-lived antibody course
8. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity
9. Invited anniversary review: HLA associated diseases
10. The inverse association between tuberculin responses and atopic disorder
11. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy
12. Response to hepatitis B vaccine: Multiple HLA genes are involved
13. Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression
14. Molecular genetics of the fourth component of human complement
15. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
16. Regulation of the B cell response to a T-dependent antigens by classical pathway complement
17. The CD19/CR2/TAPA- 1 complex of B lymphocytes linking natural to acquired immunity
18. Structural differences between the two human complement C 4 isotypes affect the humoral immune response
19. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation
20. Reference typing report for complement component C 4
21. A combination of HLA-DQ beta Asp57-negative and HLA-DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus
22. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer
23. Ancestral haplotypes: Conserved population MHC haplotypes
24. Immunogenicity of hepatitis B vaccine in term and preterm infants
25. Hepatitis B vaccination in preterm infants
26. Influence of smoking on immunological responses to hepatitis B vaccine
27. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers
28. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigens (S) or preS2 + S antigens
29. Complement and the immune response
30. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls
31. Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus